Literature DB >> 16363801

Mode of binding of methyl acceptor substrates to the adrenaline-synthesizing enzyme phenylethanolamine N-methyltransferase: implications for catalysis.

Christine L Gee1, Joel D A Tyndall, Gary L Grunewald, Qian Wu, Michael J McLeish, Jennifer L Martin.   

Abstract

Here we report three crystal structure complexes of human phenylethanolamine N-methyltransferase (PNMT), one bound with a substrate that incorporates a flexible ethanolamine side chain (p-octopamine), a second bound with a semirigid analogue substrate [cis-(1R,2S)-2-amino-1-tetralol, cis-(1R,2S)-AT], and a third with trans-(1S,2S)-2-amino-1-tetralol [trans-(1S,2S)-AT] that acts as an inhibitor of PNMT rather than a substrate. A water-mediated interaction between the critical beta-hydroxyl of the flexible ethanolamine group of p-octopamine and an acidic residue, Asp267, is likely to play a key role in positioning the side chain correctly for methylation to occur at the amine. A second interaction with Glu219 may play a lesser role. Catalysis likely occurs via deprotonation of the amine through the action of Glu185; mutation of this residue significantly reduced the kcat without affecting the Km. The mode of binding of cis-(1R,2S)-AT supports the notion that this substrate is a conformationally restrained analogue of flexible PNMT substrates, in that it forms interactions with the enzyme similar to those observed for p-octopamine. By contrast, trans-(1S,2S)-AT, an inhibitor rather than a substrate, binds in an orientation that is flipped by 180 degrees compared with cis-(1R,2S)-AT. A consequence of this flipped binding mode is that the interactions between the hydroxyl and Asp267 and Glu219 are lost. However, the amines of inhibitor trans-(1S,2S)-AT and substrate cis-(1R,2S)-AT are both within methyl transfer distance of the cofactor. These results suggest that PNMT catalyzes transfer of methyl to ligand amines only when "anchor" interactions, such as those identified for the beta-hydroxyls of p-octopamine and cis-AT, are present.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16363801     DOI: 10.1021/bi051636b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Structural basis of substrate recognition in human nicotinamide N-methyltransferase.

Authors:  Yi Peng; Davide Sartini; Valentina Pozzi; Dennis Wilk; Monica Emanuelli; Vivien C Yee
Journal:  Biochemistry       Date:  2011-08-17       Impact factor: 3.162

2.  Application of the Goldilocks effect to the design of potent and selective inhibitors of phenylethanolamine N-methyltransferase: balancing pKa and steric effects in the optimization of 3-methyl-1,2,3,4-tetrahydroisoquinoline inhibitors by beta-fluorination.

Authors:  Gary L Grunewald; Mitchell R Seim; Jian Lu; Mariam Makboul; Kevin R Criscione
Journal:  J Med Chem       Date:  2006-05-18       Impact factor: 7.446

3.  Kinetic and pH studies on human phenylethanolamine N-methyltransferase.

Authors:  Qian Wu; Michael J McLeish
Journal:  Arch Biochem Biophys       Date:  2013-09-07       Impact factor: 4.013

4.  Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors.

Authors:  Gary L Grunewald; Mitchell R Seim; Rachel C Regier; Kevin R Criscione
Journal:  Bioorg Med Chem       Date:  2006-11-10       Impact factor: 3.641

5.  Molecular recognition of physiological substrate noradrenaline by the adrenaline-synthesizing enzyme PNMT and factors influencing its methyltransferase activity.

Authors:  Nyssa Drinkwater; Christine L Gee; Munish Puri; Kevin R Criscione; Michael J McLeish; Gary L Grunewald; Jennifer L Martin
Journal:  Biochem J       Date:  2009-08-27       Impact factor: 3.857

6.  Synthesis of 4,5,6,7-tetrahydrothieno[3,2-c]pyridines and comparison with their isosteric 1,2,3,4-tetrahydroisoquinolines as inhibitors of phenylethanolamine N-methyltransferase.

Authors:  Gary L Grunewald; Mitchell R Seim; Seema R Bhat; Marc E Wilson; Kevin R Criscione
Journal:  Bioorg Med Chem       Date:  2007-10-11       Impact factor: 3.641

7.  The reaction mechanism of phenylethanolamine N-methyltransferase: a density functional theory study.

Authors:  Polina Georgieva; Qian Wu; Michael J McLeish; Fahmi Himo
Journal:  Biochim Biophys Acta       Date:  2009-09-03

8.  Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1.

Authors:  Jian Lu; Aaron G Bart; Qian Wu; Kevin R Criscione; Michael J McLeish; Emily E Scott; Gary L Grunewald
Journal:  J Med Chem       Date:  2020-11-04       Impact factor: 8.039

9.  Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.

Authors:  Uyen B Chu; Sevahn K Vorperian; Kenneth Satyshur; Kelsey Eickstaedt; Nicholas V Cozzi; Timur Mavlyutov; Abdol R Hajipour; Arnold E Ruoho
Journal:  Biochemistry       Date:  2014-04-28       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.